Exhibitors

US United States
Stand No: 3C60
AbbVie Contract Manufacturing has a portfolio of state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. For more than 30 years, AbbVie Contract Manufacturing has offered contract manufacturing services that spans biologics, potent, drug product, prefilled syringes, fermentation, as well as selling high quality active pharmaceutical ingredients (APIs).
Location:
Global CRO specialized in drug development and testing for chemical and biological molecules, partner to generic and innovator companies. Phase 1 BABE, PK studies, Phase II-III-IV clinical trials, services for Biologics and Biosimilars (Clinical comparability, PK/PD, immunogenicity, and selected characterisation services) and medical writing. Truly Independent - No stake or partnership with any pharmaceutical company 18 years consistent global track record Infrastructure, equipment and experienced team of 600+ for all challenges including FTF, 505(b)(2)s in the US Certifications: 27x successful US FDA, 20x WHO, 6x EMA, 13x ANVISA Brazil, 16X DCGI India
Location:
CA Canada
Stand No: 3A78
Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, as well as Algorithme Pharma USA in Fargo, ND, thereby making it one of the largest early phase clinical CROs in North America. With over 25 years of industry experience, Altasciences provides early phase clinical development services to an international customer base of biopharmaceutical and generic companies. Altasciences' full-service solutions offering in this critical stage of drug development includes medical writing, biostatistics, data management and bioanalysis.
Location:
US United States
Stand No: 3A51
Avara offers contract manufacturing of APIs, solid and liquid sterile drug product, and packaging from five world-class facilities. Led by highly experienced industry veterans, Avara understands clients' individual needs and focuses on providing an exceptional outsourcing experience by delivering on commitments in terms of scope, schedule, compliance and price.
Location:
NL Netherlands
Stand No: 3A100
Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation. We operate a hybrid business model combining CRO service activities with internal product development programs, whereby in both cases, we approach ‘development' as not just offering a technical solution but always part of a broader product-oriented strategy. Our expertise and capabilities are centered around the development of value-added generic drugs, life cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). Our CRO services comprises complex drug product development and analytical development with unique dissolution and excipient characterization platforms.
Location:
IN India
Stand No: 3B72
Azidus CRO, based in Chennai, India. Conducts BA/BE studies (healthy volunteers and patients), clinical trials, clinical data management, pharmacovigilance and regulatory submission to the global drug regulatory agencies. 480 Bedded Clinical facility and bio-analytical facility with 26 LC-MS/MS and three ICPMS under one roof. Approved by ANVISA Brazil, inspected by USFDA, DCGI, MOH-Turkey, GLP-Poland, UAE, Chile Health Authority, submitted studies for Spain and Germany. Clinical Laboratory approved by CAP (College of American Pathologists) and NABL.
Location:
IN India
Stand No: 3B92
Dorizoe Lifesciences Ltd is a purely Contract Research & Finished Product Development Organization based in India, working for Pharmaceutical Companies operating in Regulated Markets. We have strong capability in Finished Product Development of Parentral, Injectable (Lyophilized to Aqueous in Cytotoxic and Non Cytotoxic space) & Semi-Solids Like Creams, ointments & Gel in different delivery systems including Ampoules, Vials, PFS, PVC and Non - PVC bags and so on. At Dorizoe, we have very strong capability of developing injectables in cytotoxic to non cytotoxic space in lyophilized to aqueous form. After developing the product, we can also assist you for contract manufacturing by transferring the technology to your preferred CMO or at our recommended / preferred CMO partners. Apart from contract development, we also provide the Customized Services of Formulation and Development, Analytical Service, Quality Assurance, Regulatory Services and other Pharmaceutical Support Services. Currently we are working with the top pharmaceutical...
Location:
IE Ireland
Stand No: 3B80
New
ICON plc is a global provider of clinical development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development. With headquarters in Dublin, Ireland, ICON currently, operates from 84 locations in 38 countries and has approximately 12,300 employees. https://www.iconplc.com
Location:
NL Netherlands
Stand No: 3A92
InnoSyn offers a team of passionate & experienced problem solvers, applying innovative and cost-efficient technologies such as flow chemistry, bio- and chemo-catalysis. If you need a scalable route for your new chemical compound (INVENT), or a better yield of your current product (IMPROVE), or manufacturing capacity for your product (IMPLEMENT), InnoSyn can help.
Location:
PL Poland
Stand No: 3A80
Institute of Industrial Organic Chemistry Branch Pszczyna is a pre-clinical contract research organization specializing in toxicological and ecotoxicological studies. As a GLP (Good Laboratory Practice) certified Institute we provide a wide range of services in the fields of human health protection and environmental safety, conduct studies of: plant protection products, pharmaceutical products, veterinary medical products, food and feed additives, industrial chemicals, biocides and industrial wastes. IPO offers research services in compliance with international guidelines: OECD, EU, EPPO, EMA, US EPA, SETAC/IOBC/BART/EPPO and ISO.
Location:
DE Germany
Stand No: 3B70
Lichtenheldt is the committed full service pharmaceutical contract manufacturer and developer for non-sterile liquid and semi-solid dosage forms. Our manufacturing plant is accredited according to EU GMP and DIN EN ISO 13485 for medical products. Lichtenheldt has an ex proof production zone, store capabilities. Production and packaging under protective atmosphere is also possible. Our packaging expertise ranges from bottles, canisters, IBC bulk containers, tubes to stick packs. In addition to our manufacturing service we offer a wide range of additional service like analytical testing, galenic development, feasibility studies and regulatory services. Lichtenheldt has over 30 years of experience as a trustworthy contract manufacturer. We are the CMO-Expert for liquid and semi solids production and a first choice strategic outsourcing partner, so let's come together.
Location:
US United States
Stand No: 3A60
Lifecore has 25 years of aseptic filling experience, focused on viscous and difficult to fill solutions. "Lifecore's" expertise grew from supplying sodium hyaluronate (hyaluronic acid) as an API to its partners and then supplying them with formulation, aseptic filling, and packaging services. Lifecore also does upstream manufacturing for its partners. Lifecore offers the services you expect from a CDMO: Development, Formulation and Process Development, Analytical Method Development, Stability Testing, Technology Transfer, Equipment Design and Procurement, Pilot Batch Sizes for Syringe and Vial Configurations, Quality Systems Experience in Pharmaceutical and Medical Device Regulations, Regulatory Support Clinical and Commercial Manufacturing, Formulation, Sterile Filtration of Highly Viscous Solutions, Aseptic Filling into Syringes or Vials, Secondary Sterilization, Final Packaging, Global Supply Chain Management, Large, Efficient Batch Sizes.
Location:
RO Romania
Stand No: 3B90
Magistra C&C is a Romanian producer of pharmaceutical products. Our production lines for the manufacturing of tablets, coated tablets, suppositories, ovules, creams, ointments and gels, are GMP certified in a new facility established in 2008, updated for the newest requisites in the Pharmaceutical Industry. Besides our main involvement in the Romanian pharmaceutical market, we also export our own products in the Russian Federation, Armenia, Azerbaijan, Georgia, Ukraine, Belarus, etc. and we perform contract manufacturing for important names in the pharmaceutical field. With a vast experience in the field, Magistra C&C is your perfect partner, complying with all current EU regulations.
Location:
Categories:
IT Italy
Stand No: 3C70
Mipharm S.p.A. was born in January 1998 following the merger of Sandoz and Ciba Geigy, from which resulted the new company Novartis. Mipharm was founded by a group of ex managers coming from Novartis by mean of a spin-off of the manufacturing site located in Milan, Via Quaranta, previously owned by Sandoz. In December 2016, Mandarin Capital Partners II acquired the majority stake in Mipharm share capital. Today, Mipharm is one of the most valuable third party manufacturing and new product development sites in Italy and it claims to have four FDA approvals (Nasal Spray Solution, Oral Potent Drug, Sachet, Packaging). Mipharm has been investing significant resources to continuously improve manufacturing site qualitative standard and currently it is able to produce and to pack a huge range of products and pharmaceutical forms.
Location:
Panexcell is a well-established BA/BE centre at Mumbai, INDIA with total Bed Capacity of 58 and 21 CFR, Part 11 compliant sophisticated instruments like LCMS - API 5500. Panexcell have a comprehensive total quality management systems, standard processes specifically designed for high-quality deliverables, a sustained and reliable regulatory environment, and highly trained manpower. Services Offered in BA/BE: • Bio-Availability / Bio-Equivalence Studies • Pharmacokinetic Studies with NDDS and NCEs • Bio-analytical • Statistical Analysis • Data Management • Medical Writing • Special Population Studies Clinical Trials: • Proof of concept studies • Phase I - Phase IV Clinical studies • Disease prevalence and modality of the treatment • Safety monitoring • Pharmacovigilance • Therapeutic training Medical Writing: Our Medical writing team supports the planning and conduct of studies with utmost focus on safety. Their role comprises protocol designing, interacting with key operation leaders in specific therapeutic areas to obtain their...
Location:
IT Italy
Stand No: 3C62
Since 2005 PolyCrystalline provides reliable solutions to optimise and control the crystallisation process of Active Pharmaceutical Ingredients for pharmaceutical companies. Our mission is to support our clients during drug development, helping them to reduce batch failure, avoiding costly crystallisation issues and overall offering greater confidence in drug quality during manufacturing. We can support you from early-phase drug discovery to kilogram supply. We are a high performing cohesive team of trained chemists and analysts, with more than 10 years of experience in the development and optimization of APIs crystallization. We care about results and innovation based on sound science and the use of modern technologies.
Location:
CZ Czech Republic
Stand No: 3B82
Quinta-Analytica is a leading Central and East European contract research organization located in Prague, Czech Republic, whose primary task is to supply pharmaceutical companies with comprehensive analytical and clinical services. For both small molecules and biopharmaceuticals, Quinta-Analytica offers the following services: analytical methods development; validation and transfer for the evaluation of drug substances; intermediates and/or pharmaceutical products; also including chiral separation and impurity isolation and identification; quality control and release testing; stability studies; clinical trials; and pharmacokinetic/toxicokinetic studies in man and/or animals. Quinta-Analytica operates in full compliance with GCP/GLP/GMP and FDA standards.
Location:
IN India
Stand No: 3A83
Raptim Research Ltd. is a quality-oriented full-service contract (clinical) research organization. Raptim provides end-to-end services to global Pharmaceutical (generic as well as research-based), Biotechnology and Cosmetic industry. The studies done at Raptim are globally submitted and approved by various regulatory agencies including USFDA, EMA, UK MHRA, Canada (TPD), WHO and etc. Raptim Research Ltd., incorporated in the year 2005, has its facilities based in Navi Mumbai and Business Office in Navi Mumbai as well as New Jersey, USA. Raptim is leader following activities: Bioequivalence / Bioavailability Studies (BE/BA studies) PK end-point studies PD end-point studies Clinical trials – phase II & IV Studies on Special Population Apart from the above, Raptim has developed expertise in niche area of drug development and has pioneered in testing/screening Dermal Topical Products including Cosmetic Products as well as inhalation products. These include: In vitro Release/Permeation (IVRT/IVPT) studies In vivo – Tape Stripping studies In...
Location:
IN India
Stand No: 3A74
Synchron is India's first internationally recognized Contract Research Organization, which started its operations in 1998. Synchron undertakes Phase I to IV Clinical trials, Bio-equivalence studies, Therapeutic equivalence studies & Pk/Pd studies. We have a robust experience of conducting BE studies with the facility being audited by the regulatory agencies like MHRA, US-FDA, AFFSAPS, MoH Turkey & DCG(I). We are among the first few CROs, who initiated conduct of Phase II to IV Clinical trials in India, initially as a partner to globally recognized CRO PAREXEL, and then managing multi-centric Clinical trials on our own.
Location:
IN India
Stand No: 3A50
TherDose was initially built with a vision of creating a technology and therapeutic area research based speciality pharmaceutical company. With core expertise in the area of dosage form design and development, we are uniquely positioned to rapidly develop value added therapeutics that make a difference in people's lives. We are currently operating a partnership based model where we develop and commercialize dosage forms with corporate partners located worldwide. We specialize in developing/using drug delivery/formulation technologies that provide the highest therapeutic differentiation. After clearly establishing ourselves as a reputed R&D company, now we're envisaging the opportunities in the area of manufacturing oncology injectables, which are categorized as speciality segments, for distributing them worldwide at the most affordable prices.
Location:
GB United Kingdom
Stand No: 3A75
World Courier is a global specialty logistics company that designs world-class logistics and supply chain programs in complete alignment with our customers' business goals. Pharmaceutical companies rely on us because they value the peace of mind that comes with our unsurpassed knowledge, global reach and flawless supply chain execution. Each trusted partnership we form with a customer is deeply rooted in our shared vision of improving global health. With 2,000+ associates in more than 140 offices across the globe, we offer solutions that instill confidence in the on-time, on-temperature delivery of critical products. When trust is absolutely essential, there's only one choice: World Courier.
Location:
BE Belgium
Stand No: 3A90
Xedev is a contract development company in early stage feasibility Particle Engineering by Agglomeration / Coating / Drying. Fields of experitise are; Microencapsulation, Solid Dispersions, Controlled Release, Particle Agglomeration and Drying Development. Xedev's key to success is based on the combination of know-how in equipment engineering, process and product. The available technologies; spray dryer, fluid bed, high shear granulator, vacuum dryer, microwave dryer, nutsche filter, extruder spheroniser, homogeniser, tablet/capsule coater. Through partnerships are available; GMP infrastructure, Pre-clinical phase II, Analytical Dev, Stability and Bioequivalaent studies, Regulatory, Scale-up to pilot and production.
Location: